Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-21

Clinical Trial Update: Postoperative Dose of Parathyroid Hormone as a Marker for the Occurrence of Hypoparathyroidism After Total Thyroidectomy

View source ↗

Summary

Completed clinical trial evaluating whether postoperative parathyroid hormone dosing can predict hypoparathyroidism after total thyroidectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Parathyroid hormone (Parathyroid hormone)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Hypoparathyroidism | Status: COMPLETED